Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $163392.0.

  • Cumberland Pharmaceuticals' Free Cash Flow fell 6448.96% to $163392.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 52364.17%. This contributed to the annual value of -$678647.0 for FY2024, which is 11167.55% down from last year.
  • Cumberland Pharmaceuticals' Free Cash Flow amounted to $163392.0 in Q3 2025, which was down 6448.96% from $817315.0 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Free Cash Flow high stood at $5.2 million for Q2 2023, and its period low was -$2.2 million during Q1 2024.
  • For the 5-year period, Cumberland Pharmaceuticals' Free Cash Flow averaged around $1.3 million, with its median value being $1.2 million (2023).
  • Its Free Cash Flow has fluctuated over the past 5 years, first surged by 167068.18% in 2022, then plummeted by 75949.66% in 2023.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Free Cash Flow stood at $2.0 million in 2021, then skyrocketed by 94.38% to $3.8 million in 2022, then plummeted by 73.85% to $991448.0 in 2023, then skyrocketed by 91.87% to $1.9 million in 2024, then tumbled by 91.41% to $163392.0 in 2025.
  • Its Free Cash Flow was $163392.0 in Q3 2025, compared to $817315.0 in Q2 2025 and $3.9 million in Q1 2025.